
Rokson Pharmaceuticals Private Limited
About Rokson Pharmaceuticals Private Limited
Data last updated:
Rokson Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 24 February 2011.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24230MH2011PTC213998. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Poonam Sunil Mishra and Sunil Shatrughan Mishra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 55 Netaji Society Near Nisarg Garden Lawn Katol Road, Nagpur, Maharashtra, India – 440013.
As per the financials filed for FY 2024, the company reported a revenue of ₹2 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.63 Lakh (net margin 81.4%) and EBITDA of ₹1.66 Lakh (EBITDA margin 82.8%). Revenue has grown at a compounded annual rate (CAGR) of 102% over three years and 54% over five years.
Company details
Contact details
Rokson Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 55 Netaji Society Near Nisarg Garden Lawn Katol Road, Nagpur, Maharashtra, India – 440013
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Rokson Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rokson Pharmaceuticals Private Limited
FY 2024 filings availableRokson Pharmaceuticals Private Limited reported revenue of ₹2 Lakh (up 300% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 54% over five years, including 300% growth in the latest year. EBITDA rose 436% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.63 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 82.8% | ||||
| Net Profit Margin | 81.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rokson Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rokson Pharmaceuticals Private Limited
Rokson Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Sunil Mishra Also directs: Prithvi International Private Limited | Director | 24 Feb 2011 | 15 Years 7 Months | Current |
| Sunil Shatrughan Mishra | Director | 24 Feb 2011 | 15 Years 7 Months | Current |
Auditor
Rokson Pharmaceuticals Private Limited is audited by AMIT R SURANA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT R SURANA & CO | FY 2020 | 127396W |
Shareholding
The shareholding of Rokson Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Rokson Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rokson Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rokson Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rokson Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Rokson Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rokson Pharmaceuticals Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Sangit Ashokrao Chauhan ceased to be Director on 09 Apr 2019.
Frequently asked questions
Rokson Pharmaceuticals is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Rokson Pharmaceuticals is a company pending strike off, currently registered as a private limited company based in Nagpur, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 24 February 2011 and is registered under CIN U24230MH2011PTC213998. The company may be struck off soon - caution is advised.
The compliance status of Rokson Pharmaceuticals is compliant as of 14 July 2026.
Rokson Pharmaceuticals has 2 current directors:
- Poonam Sunil Mishra - Director
- Sunil Shatrughan Mishra - Director
The CIN (Corporate Identification Number) of Rokson Pharmaceuticals is U24230MH2011PTC213998. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rokson Pharmaceuticals was incorporated on 24 February 2011. It is registered with the Registrar of Companies, Nagpur.
The registered office of Rokson Pharmaceuticals is at Plot No. 55 Netaji Society Near Nisarg Garden Lawn Katol Road, Nagpur, Maharashtra, India – 440013.
The latest financial statements of Rokson Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Rokson Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
Rokson Pharmaceuticals operates in the healthcare industry, in the ayurvedic products and services segment.